These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10730740

  • 1. Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs.
    Takahashi S, Fujii Y, Hoshi T, Inomata S, Miyabe M, Toyooka H.
    Can J Anaesth; 2000 Mar; 47(3):265-72. PubMed ID: 10730740
    [Abstract] [Full Text] [Related]

  • 2. Landiolol decreases a dysrhythmogenic dose of epinephrine in dogs during halothane anesthesia.
    Takahashi S, Fujii Y, Inomata S, Miyabe M, Toyooka H.
    Can J Anaesth; 1999 Jun; 46(6):599-604. PubMed ID: 10391611
    [Abstract] [Full Text] [Related]

  • 3. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
    Hoshi T, Sato A, Nishina H, Kakefuda Y, Wang Z, Noguchi Y, Aonuma K.
    J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733
    [Abstract] [Full Text] [Related]

  • 4. The effects of esmolol on the hemodynamics of acute theophylline toxicity.
    Gaar GG, Banner W, Laddu AR.
    Ann Emerg Med; 1987 Dec; 16(12):1334-9. PubMed ID: 3688594
    [Abstract] [Full Text] [Related]

  • 5. Milrinone attenuates the negative inotropic effects of landiolol in halothane-anesthetized dogs.
    Takahashi S, Fujii Y, Hoshi T, Uemura A, Miyabe M, Toyooka H.
    Can J Anaesth; 2003 Oct; 50(8):830-4. PubMed ID: 14525825
    [Abstract] [Full Text] [Related]

  • 6. Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
    Kobayashi S, Susa T, Tanaka T, Murakami W, Fukuta S, Okuda S, Doi M, Wada Y, Nao T, Yamada J, Okamura T, Yano M, Matsuzaki M.
    Circ J; 2012 Oct; 76(7):1646-53. PubMed ID: 22481100
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low-Dose Landiolol Reduces Heart Rate and Cardiac Oxygen Consumption Without Compromising Initial Hemodynamic Resuscitation in a Canine Model of Endotoxin Shock.
    Uemura K, Kawada T, Zheng C, Li M, Sugimachi M.
    Shock; 2019 Jul; 52(1):102-110. PubMed ID: 30052577
    [Abstract] [Full Text] [Related]

  • 9. Continuous administration of landiolol reduced QT dispersion in postoperative patients.
    Suzuki K, Numaguchi A, Adachi YU, Obata Y, Hatano T, Ejima T, Sato S, Matsuda N.
    J Clin Anesth; 2014 Sep; 26(6):438-42. PubMed ID: 25204509
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
    Taenaka N, Kikawa S.
    Am J Cardiovasc Drugs; 2013 Oct; 13(5):353-64. PubMed ID: 23818039
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Addition of a β1-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation.
    Kobayashi S, Myoren T, Kajii T, Kohno M, Nanno T, Ishiguchi H, Nishimura S, Fukuda M, Hino A, Fujimura T, Ono M, Uchinoumi H, Tateishi H, Mochizuki M, Oda T, Okuda S, Yoshiga Y, Kawano R, Yano M.
    Cardiology; 2019 Oct; 142(4):195-202. PubMed ID: 31137022
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
    Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, Nagano T, Morishima E, Matsuda N, J-Land 3S Study Group.
    Lancet Respir Med; 2020 Sep; 8(9):863-872. PubMed ID: 32243865
    [Abstract] [Full Text] [Related]

  • 18. Use of a Short-Acting β1 Blocker During Endotoxemia May Reduce Cerebral Tissue Oxygenation if Hemodynamics are Depressed by a Decrease in Heart Rate.
    Kurita T, Kawashima S, Morita K, Nakajima Y.
    Shock; 2017 Jun; 47(6):765-771. PubMed ID: 28505021
    [Abstract] [Full Text] [Related]

  • 19. The effect of landiolol on cerebral blood flow in patients undergoing off-pump coronary artery bypass surgery.
    Goto K, Hagiwara S, Hidaka S, Yamamoto S, Kusaka J, Yasuda N, Shingu C, Noguchi T.
    J Anesth; 2010 Feb; 24(1):11-6. PubMed ID: 20052497
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
    Hirota K, Baba S, Fukushi S, Muraoka M, Matsuki A.
    J Anesth; 2005 Feb; 19(1):17-20. PubMed ID: 15674510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.